Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI
$ 2.26 8.73%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Brainstorm Cell Therapeutics Long Term Debt Current 2011-2024 | BCLI

Annual Long Term Debt Current Brainstorm Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
603 K 1.43 M 1.46 M 2.66 M 1.26 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.66 M 603 K 1.48 M